Published in
Elsevier, Contemporary Clinical Trials Communications, (26), p. 100891, 2022
DOI: 10.1016/j.conctc.2022.100891
Links
Tools
Rationale and study design of a trial to assess rTMS add-on value for the amelioration of negative symptoms of schizophrenia (RADOVAN)
Journal article published in 2022 by
T. Hebel 
,
B. Langguth,
M. Schecklmann,
S. Schoisswohl,
S. Staudinger,
A. Schiller,
L. Ustohal ,
T. Sverak,
M. Horky,
T. Kasparek,
T. Skront ,
M. Hyza,
T. B. Poeppl ,
M. L. Riester,
L. Schwemmer
and other authors.
,
B. Langguth,
M. Schecklmann,
S. Schoisswohl,
S. Staudinger,
A. Schiller,
L. Ustohal ,
T. Sverak,
M. Horky,
T. Kasparek,
T. Skront ,
M. Hyza,
T. B. Poeppl ,
M. L. Riester,
L. Schwemmer
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 